We serve Chemical Name:5-bromo-2,3-dichloro-4-methylpyridine CAS:1246647-17-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-bromo-2,3-dichloro-4-methylpyridine
CAS.NO:1246647-17-5
Synonyms:i02-1965
Molecular Formula:C6H4BrCl2N
Molecular Weight:240.91300
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:238.89000
LogP:3.45930
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like i02-1965 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,i02-1965 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,i02-1965 Use and application,i02-1965 technical grade,usp/ep/jp grade.
Related News: But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 5-bromo-2,3-dichloro-4-methylpyridine manufacturer China’s basic chemical industry is developed, and the intermediate industry has also entered a mature stage. It is basically able to independently support the production needs of various domestic drug substances, which also brings cost advantages to Chinese drug substance companies. On the other hand, if there is insufficient supply of upstream products or price fluctuations, the sales of API products will also fluctuate in volume and price. 5-bromo-2,3-dichloro-4-methylpyridine supplier In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China. 5-bromo-2,3-dichloro-4-methylpyridine vendor But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. 5-bromo-2,3-dichloro-4-methylpyridine factory But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone.
